41 'Safer' Dividend Healthcare Pre-December WallStars From Dividend Dogcatcher

Source: YCharts
Actionable Conclusions (1-10): Brokers Forecast Ten High Yield Top Healthcare 'Safer' Dividend Stocks to Net 12.6% to 26.75% Gains To November 2019
Four of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1-year target prices, the dog strategy for this Health group graded out as 40% accurate.
Projections based on estimated dividends from $1,000 invested in the ten highest yielding Healthcare stocks, and aggregate one-year analyst mean target prices for tho stocks, as reported by YCharts, created the 2019 data points. Note: one-year target prices from one analyst were not applied (n/a). Ten probable profit-generating trades to 2019 were:
Gilead Sciences (GILD) netted $267.47 based on estimates from twenty-seven analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 1% more than the market as a whole.
Fresenius Medical Care (FMS) netted $196.12 based on dividends plus median target price estimate from six analysts less broker fees. The Beta number 11% over the market as a whole.
Bristol-Myers Squibb Co (BMY) netted $173.08 based on estimates from eighteen analysts, plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 8% more than the market as a whole.
Zimmer Biomet Holdings (ZBH) netted $167.10 based on a median target... Read more